Fusion of calreticulinto the tumor antigens was used to improve the T–cell immune response against tumor cells.A DNA–vaccine that encoded a fusion of CRT with Е 7 protein ofhuman papilloma virus 16 (HPV–16) was created. Here, CALR is linked to neoplasm.